FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328109462> ?p ?o ?g. }

• W4328109462 endingPage "1877" @default.
• W4328109462 startingPage "1877" @default.
• W4328109462 abstract "Purpose: We assessed whether preoperativemutational analyses of circulating tumor cells (CTCs) and plasma-cfDNA could be used as minimally invasive biomarkers and as complimentary tools for early prediction of relapse in early-stage non-small -cell lung cancer (NSCLC). Experimental Design: Using ddPCR assays, hotspot mutations of BRAF, KRAS, EGFR and PIK3CA were identified in plasma-cfDNA samples and size-based enriched CTCs isolated from the same blood samples of 49 early-stage NSCLC patients before surgery and in a control group of healthy blood donors (n= 22). Direct concordance of the mutational spectrum was further evaluated in 27 patient-matched plasma-cfDNA and CTC-derived DNA in comparison to tissue-derived DNA. Results: The prevalence of detectable mutations of the four tested genes was higher in CTC-derived DNA than in the corresponding plasma-cfDNA (38.8% and 24.5%, respectively).The most commonly mutated gene was PIK3CA, in both CTCs and plasma-cfDNA at baseline and at the time of relapse. Direct comparison of the mutation status of selected drug-responsive genes in CTC-derived DNA, corresponding plasma-cfDNA and paired primary FFPE tissues clearly showed the impact of heterogeneity both within a sample type, as well as between different sample components. The incidence of relapse was higher when at least one mutation was detected in CTC-derived DNA or plasma-cfDNA compared with patients in whom no mutation was detected (p =0.023). Univariate analysis showed a significantly higher risk of progression (HR: 2.716; 95% CI, 1.030–7.165; p =0.043) in patients with detectable mutations in plasma-cfDNA compared with patients with undetectable mutations, whereas the hazard ratio was higher when at least one mutation was detected in CTC-derived DNA or plasma-cfDNA (HR: 3.375; 95% CI, 1.098–10.375; p =0.034). Conclusions: Simultaneous mutational analyses of plasma-cfDNA and CTC-derived DNA provided complementary molecular information from the same blood sample and greater diversity in genomic information for cancer treatment and prognosis. The detection of specific mutations in ctDNA and CTCs in patients with early-stage NSCLC before surgery was independently associated with disease recurrence, which represents an important stratification factor for future trials." @default.
• W4328109462 created "2023-03-22" @default.
• W4328109462 creator A5004036452 @default.
• W4328109462 creator A5014087122 @default.
• W4328109462 creator A5023436565 @default.
• W4328109462 creator A5041623899 @default.
• W4328109462 creator A5045591899 @default.
• W4328109462 creator A5050764803 @default.
• W4328109462 creator A5077410158 @default.
• W4328109462 creator A5080568812 @default.
• W4328109462 creator A5082494413 @default.
• W4328109462 date "2023-03-21" @default.
• W4328109462 modified "2023-09-30" @default.
• W4328109462 title "Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer" @default.
• W4328109462 cites W2038268416 @default.
• W4328109462 cites W2038377030 @default.
• W4328109462 cites W2098665230 @default.
• W4328109462 cites W2108371618 @default.
• W4328109462 cites W2116636854 @default.
• W4328109462 cites W2149968797 @default.
• W4328109462 cites W2153733592 @default.
• W4328109462 cites W2154974159 @default.
• W4328109462 cites W2239287815 @default.
• W4328109462 cites W2269331124 @default.
• W4328109462 cites W2284393155 @default.
• W4328109462 cites W2511430943 @default.
• W4328109462 cites W2608738563 @default.
• W4328109462 cites W2609243345 @default.
• W4328109462 cites W2728387909 @default.
• W4328109462 cites W2766316939 @default.
• W4328109462 cites W2767867768 @default.
• W4328109462 cites W2783350974 @default.
• W4328109462 cites W2801911503 @default.
• W4328109462 cites W2810592374 @default.
• W4328109462 cites W2947724114 @default.
• W4328109462 cites W2955371778 @default.
• W4328109462 cites W2966632204 @default.
• W4328109462 cites W2971041600 @default.
• W4328109462 cites W2978258146 @default.
• W4328109462 cites W3007511407 @default.
• W4328109462 cites W3016825230 @default.
• W4328109462 cites W3080458669 @default.
• W4328109462 cites W3091799390 @default.
• W4328109462 cites W3095861953 @default.
• W4328109462 cites W3122882833 @default.
• W4328109462 cites W3124204822 @default.
• W4328109462 cites W3134004960 @default.
• W4328109462 cites W3164556595 @default.
• W4328109462 cites W3167843360 @default.
• W4328109462 cites W3170134743 @default.
• W4328109462 cites W3206624031 @default.
• W4328109462 cites W3206816075 @default.
• W4328109462 cites W4206841660 @default.
• W4328109462 cites W4280554654 @default.
• W4328109462 cites W4285097954 @default.
• W4328109462 doi "https://doi.org/10.3390/cancers15061877" @default.
• W4328109462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36980762" @default.
• W4328109462 hasPublicationYear "2023" @default.
• W4328109462 type Work @default.
• W4328109462 citedByCount "2" @default.
• W4328109462 countsByYear W43281094622023 @default.
• W4328109462 crossrefType "journal-article" @default.
• W4328109462 hasAuthorship W4328109462A5004036452 @default.
• W4328109462 hasAuthorship W4328109462A5014087122 @default.
• W4328109462 hasAuthorship W4328109462A5023436565 @default.
• W4328109462 hasAuthorship W4328109462A5041623899 @default.
• W4328109462 hasAuthorship W4328109462A5045591899 @default.
• W4328109462 hasAuthorship W4328109462A5050764803 @default.
• W4328109462 hasAuthorship W4328109462A5077410158 @default.
• W4328109462 hasAuthorship W4328109462A5080568812 @default.
• W4328109462 hasAuthorship W4328109462A5082494413 @default.
• W4328109462 hasBestOaLocation W43281094621 @default.
• W4328109462 hasConcept C104317684 @default.
• W4328109462 hasConcept C121608353 @default.
• W4328109462 hasConcept C126322002 @default.
• W4328109462 hasConcept C143998085 @default.
• W4328109462 hasConcept C144301174 @default.
• W4328109462 hasConcept C146357865 @default.
• W4328109462 hasConcept C151730666 @default.
• W4328109462 hasConcept C152110520 @default.
• W4328109462 hasConcept C160798450 @default.
• W4328109462 hasConcept C172680121 @default.
• W4328109462 hasConcept C2776256026 @default.
• W4328109462 hasConcept C2778258057 @default.
• W4328109462 hasConcept C2779013556 @default.
• W4328109462 hasConcept C2779234561 @default.
• W4328109462 hasConcept C2779529041 @default.
• W4328109462 hasConcept C2781187634 @default.
• W4328109462 hasConcept C38180746 @default.
• W4328109462 hasConcept C48126324 @default.
• W4328109462 hasConcept C49105822 @default.
• W4328109462 hasConcept C502942594 @default.
• W4328109462 hasConcept C526805850 @default.
• W4328109462 hasConcept C54355233 @default.
• W4328109462 hasConcept C61238886 @default.
• W4328109462 hasConcept C71924100 @default.
• W4328109462 hasConcept C86803240 @default.
• W4328109462 hasConceptScore W4328109462C104317684 @default.

• next